Abstract
Catheterization and Cardiovascular InterventionsVolume 81, Issue 2 p. 340-341 Peripheral Vascular Disease Pushing the boundaries of renal denervation for resistant hypertension Deepak L. Bhatt MD, MPH, FSCAI, Corresponding Author Deepak L. Bhatt MD, MPH, FSCAI VA Boston Healthcare System, Brigham and Women's Hospital, and Harvard Medical School, Boston, MassachusettsCorrespondence to: Deepak L. Bhatt, MD, MPH, FSCAI, Professor of Medicine, Harvard Medical School, VA Boston Healthcare System, 1400 VFW Parkway, Boston, MA 02132. E-mail: dlbhattmd@post.harvard.eduSearch for more papers by this author Deepak L. Bhatt MD, MPH, FSCAI, Corresponding Author Deepak L. Bhatt MD, MPH, FSCAI VA Boston Healthcare System, Brigham and Women's Hospital, and Harvard Medical School, Boston, MassachusettsCorrespondence to: Deepak L. Bhatt, MD, MPH, FSCAI, Professor of Medicine, Harvard Medical School, VA Boston Healthcare System, 1400 VFW Parkway, Boston, MA 02132. E-mail: dlbhattmd@post.harvard.eduSearch for more papers by this author First published: 19 February 2013 https://doi.org/10.1002/ccd.24785Citations: 1 Conflict of interest: Dr.Bhatt discloses the following relationships—Advisory Board: Medscape Cardiology; Board of Directors: Boston VA Research Institute, Society of Chest Pain Centers; Chair: American Heart Association Get With The Guidelines Science Subcommittee; Honoraria: American College of Cardiology (Editor, Clinical Trials, Cardiosource), Duke Clinical Research Institute (clinical trial steering committees), Slack Publications (Chief Medical Editor, Cardiology Today Intervention), WebMD (CME steering committees); Other: Senior Associate Editor, Journal of Invasive Cardiology; Research Grants: Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic (co-PI of the Symplicity HTN-3 renal denervation trial), Sanofi Aventis, The Medicines Company; Unfunded Research: FlowCo, PLx Pharma, Takeda. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume81, Issue2February 2013Pages 340-341 SCAI Member Sign in RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
